258 related articles for article (PubMed ID: 30287408)
21. Development and in vitro Evaluation of Gastro-protective Aceclofenac-loaded Self-emulsifying Drug Delivery System.
Jianxian C; Saleem K; Ijaz M; Ur-Rehman M; Murtaza G; Asim MH
Int J Nanomedicine; 2020; 15():5217-5226. PubMed ID: 32801687
[TBL] [Abstract][Full Text] [Related]
22. Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation.
Thakkar PJ; Madan P; Lin S
Pharm Dev Technol; 2014 May; 19(3):373-84. PubMed ID: 23634780
[TBL] [Abstract][Full Text] [Related]
23. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
24. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
Sharma G; Goyal H; Thakur K; Raza K; Katare OP
Drug Deliv; 2016 Oct; 23(8):3135-3145. PubMed ID: 26960815
[TBL] [Abstract][Full Text] [Related]
25. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation.
Đorđević SM; Cekić ND; Savić MM; Isailović TM; Ranđelović DV; Marković BD; Savić SR; Timić Stamenić T; Daniels R; Savić SD
Int J Pharm; 2015 Sep; 493(1-2):40-54. PubMed ID: 26209070
[TBL] [Abstract][Full Text] [Related]
26. Nanocarrier-based topical drug delivery for an antifungal drug.
Hussain A; Samad A; Nazish I; Ahmed FJ
Drug Dev Ind Pharm; 2014 Apr; 40(4):527-41. PubMed ID: 23627443
[TBL] [Abstract][Full Text] [Related]
27. Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery.
Katara R; Sachdeva S; Majumdar DK
Pharm Dev Technol; 2019 Mar; 24(3):368-379. PubMed ID: 29897843
[TBL] [Abstract][Full Text] [Related]
28. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
Carmona-Moran CA; Zavgorodnya O; Penman AD; Kharlampieva E; Bridges SL; Hergenrother RW; Singh JA; Wick TM
Int J Pharm; 2016 Jul; 509(1-2):465-476. PubMed ID: 27260133
[TBL] [Abstract][Full Text] [Related]
29. Urate crystal degradation for treatment of gout: a nanoparticulate combination therapy approach.
Tiwari S; Dwivedi H; Kymonil KM; Saraf SA
Drug Deliv Transl Res; 2015 Jun; 5(3):219-30. PubMed ID: 25787730
[TBL] [Abstract][Full Text] [Related]
30. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
31. Nanomiemgel--a novel drug delivery system for topical application--in vitro and in vivo evaluation.
Somagoni J; Boakye CH; Godugu C; Patel AR; Mendonca Faria HA; Zucolotto V; Singh M
PLoS One; 2014; 9(12):e115952. PubMed ID: 25546392
[TBL] [Abstract][Full Text] [Related]
32. Development of aceclofenac nanovesicular system using biomaterial for transdermal delivery: physical characterization, ex vivo, in vivo, and anti-inflammatory studies.
Gaur PK; Purohit S; Mishra S
J Biomater Sci Polym Ed; 2013; 24(18):2126-41. PubMed ID: 23944964
[TBL] [Abstract][Full Text] [Related]
33. Investigation of true nanoemulsions for transdermal potential of indomethacin: characterization, rheological characteristics, and ex vivo skin permeation studies.
Shakeel F; Ramadan W; Ahmed MA
J Drug Target; 2009 Jul; 17(6):435-41. PubMed ID: 19527114
[TBL] [Abstract][Full Text] [Related]
34. Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation.
Nasr M; Mansour S; Mortada ND; El Shamy AA
AAPS PharmSciTech; 2008; 9(1):154-62. PubMed ID: 18446476
[TBL] [Abstract][Full Text] [Related]
35. Coating formulations for microneedles.
Gill HS; Prausnitz MR
Pharm Res; 2007 Jul; 24(7):1369-80. PubMed ID: 17385011
[TBL] [Abstract][Full Text] [Related]
36. Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation.
Fouad SA; Basalious EB; El-Nabarawi MA; Tayel SA
Int J Pharm; 2013 Sep; 453(2):569-78. PubMed ID: 23792042
[TBL] [Abstract][Full Text] [Related]
37. Effects of lecithin-based nanoemulsions on skin: Short-time cytotoxicity MTT and BrdU studies, skin penetration of surfactants and additives and the delivery of curcumin.
Vater C; Hlawaty V; Werdenits P; Cichoń MA; Klang V; Elbe-Bürger A; Wirth M; Valenta C
Int J Pharm; 2020 Apr; 580():119209. PubMed ID: 32165223
[TBL] [Abstract][Full Text] [Related]
38. Chitosan cocrystals embedded alginate beads for enhancing the solubility and bioavailability of aceclofenac.
Ganesh M; Jeon UJ; Ubaidulla U; Hemalatha P; Saravanakumar A; Peng MM; Jang HT
Int J Biol Macromol; 2015 Mar; 74():310-7. PubMed ID: 25557368
[TBL] [Abstract][Full Text] [Related]
39. [High performance liquid chromatographic assay for aceclofenac in plasma and its pharmacokinetics in dogs].
Liu XQ; Chen XJ; Zhao LH; Peng JH
Yao Xue Xue Bao; 1997 Jul; 32(7):546-8. PubMed ID: 11596282
[TBL] [Abstract][Full Text] [Related]
40. Influence of the formulation on the in vitro transdermal penetration of sodium diclofenac. Evaluation of the topical and systemic anti-inflammatory activity in the rat.
Calpena AC; Escribano E; San Martin H; Lauroba J; Obach R; Domenech J
Arzneimittelforschung; 1999 Dec; 49(12):1012-7. PubMed ID: 10635447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
